| Gregory R Toczyl, MD | |
|
415 S 28th Ave, Hattiesburg, MS 39401-7246 | |
| (601) 579-5459 | |
| (601) 579-5240 |
| Full Name | Gregory R Toczyl |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 22 Years |
| Location | 415 S 28th Ave, Hattiesburg, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104002047 | NPI | - | NPPES |
| 02339062 | Medicaid | MS |
| Facility Name | Location | Facility Type |
|---|---|---|
| Forrest General Hospital | Hattiesburg, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fgh Physician Billing | 1850344946 | 23 |
| Forrest County General Hospital | 1052397767 | 85 |
News Archive
A research team led by Fergus Couch, Ph.D., a geneticist at Mayo Clinic, has identified specific genes associated with an increased risk for developing triple-negative breast cancer. Their research was published in the Journal of the National Cancer Institute.
A 10-minute, one-time burst of exercise can measurably boost your brain power, at least temporarily, researchers at Western University in London, Canada, have found.
Hospital readmissions are miserable for patients, and a huge cost - more than $17 billion a year in avoidable Medicare bills alone - for a nation struggling with the price of health care. Now, with Medicare fining facilities that don't reduce readmissions enough, the nation is at a crossroads as hospitals begin to take action.
High cholesterol, hypertension, diabetes and smoking have long been considered - and aggressively treated - as risk factors for cardiovascular disease.
Abbott and Neurocrine Biosciences, Inc. today announced that they have entered into a collaboration agreement to develop and commercialize elagolix for the treatment of endometriosis-related pain. Elagolix is a novel, first-in-class oral gonadotropin-releasing hormone (GnRH) antagonist, which has recently completed a phase IIb study in endometriosis. In addition to endometriosis, elagolix will be evaluated for the treatment of uterine fibroids.
› Verified 8 days ago
| Entity Name | Hattiesburg Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740213446 PECOS PAC ID: 5193706794 Enrollment ID: O20040528000685 |
News Archive
A research team led by Fergus Couch, Ph.D., a geneticist at Mayo Clinic, has identified specific genes associated with an increased risk for developing triple-negative breast cancer. Their research was published in the Journal of the National Cancer Institute.
A 10-minute, one-time burst of exercise can measurably boost your brain power, at least temporarily, researchers at Western University in London, Canada, have found.
Hospital readmissions are miserable for patients, and a huge cost - more than $17 billion a year in avoidable Medicare bills alone - for a nation struggling with the price of health care. Now, with Medicare fining facilities that don't reduce readmissions enough, the nation is at a crossroads as hospitals begin to take action.
High cholesterol, hypertension, diabetes and smoking have long been considered - and aggressively treated - as risk factors for cardiovascular disease.
Abbott and Neurocrine Biosciences, Inc. today announced that they have entered into a collaboration agreement to develop and commercialize elagolix for the treatment of endometriosis-related pain. Elagolix is a novel, first-in-class oral gonadotropin-releasing hormone (GnRH) antagonist, which has recently completed a phase IIb study in endometriosis. In addition to endometriosis, elagolix will be evaluated for the treatment of uterine fibroids.
› Verified 8 days ago
| Entity Name | Jackson Neurosurgery Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740364785 PECOS PAC ID: 1254315088 Enrollment ID: O20040617000789 |
News Archive
A research team led by Fergus Couch, Ph.D., a geneticist at Mayo Clinic, has identified specific genes associated with an increased risk for developing triple-negative breast cancer. Their research was published in the Journal of the National Cancer Institute.
A 10-minute, one-time burst of exercise can measurably boost your brain power, at least temporarily, researchers at Western University in London, Canada, have found.
Hospital readmissions are miserable for patients, and a huge cost - more than $17 billion a year in avoidable Medicare bills alone - for a nation struggling with the price of health care. Now, with Medicare fining facilities that don't reduce readmissions enough, the nation is at a crossroads as hospitals begin to take action.
High cholesterol, hypertension, diabetes and smoking have long been considered - and aggressively treated - as risk factors for cardiovascular disease.
Abbott and Neurocrine Biosciences, Inc. today announced that they have entered into a collaboration agreement to develop and commercialize elagolix for the treatment of endometriosis-related pain. Elagolix is a novel, first-in-class oral gonadotropin-releasing hormone (GnRH) antagonist, which has recently completed a phase IIb study in endometriosis. In addition to endometriosis, elagolix will be evaluated for the treatment of uterine fibroids.
› Verified 8 days ago
| Entity Name | Forrest County General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295837631 PECOS PAC ID: 1052397767 Enrollment ID: O20040624001351 |
News Archive
A research team led by Fergus Couch, Ph.D., a geneticist at Mayo Clinic, has identified specific genes associated with an increased risk for developing triple-negative breast cancer. Their research was published in the Journal of the National Cancer Institute.
A 10-minute, one-time burst of exercise can measurably boost your brain power, at least temporarily, researchers at Western University in London, Canada, have found.
Hospital readmissions are miserable for patients, and a huge cost - more than $17 billion a year in avoidable Medicare bills alone - for a nation struggling with the price of health care. Now, with Medicare fining facilities that don't reduce readmissions enough, the nation is at a crossroads as hospitals begin to take action.
High cholesterol, hypertension, diabetes and smoking have long been considered - and aggressively treated - as risk factors for cardiovascular disease.
Abbott and Neurocrine Biosciences, Inc. today announced that they have entered into a collaboration agreement to develop and commercialize elagolix for the treatment of endometriosis-related pain. Elagolix is a novel, first-in-class oral gonadotropin-releasing hormone (GnRH) antagonist, which has recently completed a phase IIb study in endometriosis. In addition to endometriosis, elagolix will be evaluated for the treatment of uterine fibroids.
› Verified 8 days ago
| Entity Name | Fgh Physician Billing |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053469700 PECOS PAC ID: 1850344946 Enrollment ID: O20050301000617 |
News Archive
A research team led by Fergus Couch, Ph.D., a geneticist at Mayo Clinic, has identified specific genes associated with an increased risk for developing triple-negative breast cancer. Their research was published in the Journal of the National Cancer Institute.
A 10-minute, one-time burst of exercise can measurably boost your brain power, at least temporarily, researchers at Western University in London, Canada, have found.
Hospital readmissions are miserable for patients, and a huge cost - more than $17 billion a year in avoidable Medicare bills alone - for a nation struggling with the price of health care. Now, with Medicare fining facilities that don't reduce readmissions enough, the nation is at a crossroads as hospitals begin to take action.
High cholesterol, hypertension, diabetes and smoking have long been considered - and aggressively treated - as risk factors for cardiovascular disease.
Abbott and Neurocrine Biosciences, Inc. today announced that they have entered into a collaboration agreement to develop and commercialize elagolix for the treatment of endometriosis-related pain. Elagolix is a novel, first-in-class oral gonadotropin-releasing hormone (GnRH) antagonist, which has recently completed a phase IIb study in endometriosis. In addition to endometriosis, elagolix will be evaluated for the treatment of uterine fibroids.
› Verified 8 days ago
| Entity Name | Pain Consultants Of South Mississippi Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619920584 PECOS PAC ID: 8628015369 Enrollment ID: O20050413001026 |
News Archive
A research team led by Fergus Couch, Ph.D., a geneticist at Mayo Clinic, has identified specific genes associated with an increased risk for developing triple-negative breast cancer. Their research was published in the Journal of the National Cancer Institute.
A 10-minute, one-time burst of exercise can measurably boost your brain power, at least temporarily, researchers at Western University in London, Canada, have found.
Hospital readmissions are miserable for patients, and a huge cost - more than $17 billion a year in avoidable Medicare bills alone - for a nation struggling with the price of health care. Now, with Medicare fining facilities that don't reduce readmissions enough, the nation is at a crossroads as hospitals begin to take action.
High cholesterol, hypertension, diabetes and smoking have long been considered - and aggressively treated - as risk factors for cardiovascular disease.
Abbott and Neurocrine Biosciences, Inc. today announced that they have entered into a collaboration agreement to develop and commercialize elagolix for the treatment of endometriosis-related pain. Elagolix is a novel, first-in-class oral gonadotropin-releasing hormone (GnRH) antagonist, which has recently completed a phase IIb study in endometriosis. In addition to endometriosis, elagolix will be evaluated for the treatment of uterine fibroids.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory R Toczyl, MD 415 S 28th Ave, Hattiesburg, MS 39401-7246 Ph: (601) 579-5459 | Gregory R Toczyl, MD 415 S 28th Ave, Hattiesburg, MS 39401-7246 Ph: (601) 579-5459 |
News Archive
A research team led by Fergus Couch, Ph.D., a geneticist at Mayo Clinic, has identified specific genes associated with an increased risk for developing triple-negative breast cancer. Their research was published in the Journal of the National Cancer Institute.
A 10-minute, one-time burst of exercise can measurably boost your brain power, at least temporarily, researchers at Western University in London, Canada, have found.
Hospital readmissions are miserable for patients, and a huge cost - more than $17 billion a year in avoidable Medicare bills alone - for a nation struggling with the price of health care. Now, with Medicare fining facilities that don't reduce readmissions enough, the nation is at a crossroads as hospitals begin to take action.
High cholesterol, hypertension, diabetes and smoking have long been considered - and aggressively treated - as risk factors for cardiovascular disease.
Abbott and Neurocrine Biosciences, Inc. today announced that they have entered into a collaboration agreement to develop and commercialize elagolix for the treatment of endometriosis-related pain. Elagolix is a novel, first-in-class oral gonadotropin-releasing hormone (GnRH) antagonist, which has recently completed a phase IIb study in endometriosis. In addition to endometriosis, elagolix will be evaluated for the treatment of uterine fibroids.
› Verified 8 days ago
Dr. Frank Joseph Hux, DO Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-579-5459 Fax: 601-268-5733 | |
Charles R Brent, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1212 South 28th Ave, Hattiesburg, MS 39402 Phone: 601-475-2430 | |
Richard Elwood Clatterbuck, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-579-5459 Fax: 601-268-5733 | |
Bradley T Hall, DO Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-579-5459 Fax: 601-268-5733 | |
Dr. Kerry L Bernardo, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 3688 Veterans Memorial Drive, Suite 200, Hattiesburg, MS 39401 Phone: 601-554-7400 Fax: 601-554-7499 | |
Dr. Michael W Lowry, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 200 Hospital Dr W, Hattiesburg, MS 39402 Phone: 601-296-3000 Fax: 601-296-3001 |